Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 24
- Registration Number
- NCT00649805
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 24
- Registration Number
- NCT00647894
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 54
- Registration Number
- NCT00649519
- Locations
- 🇺🇸
Kendle International Inc., Morgantown, West Virginia, United States
Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 30
- Registration Number
- NCT00647855
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Divalproex Sodium Extended-Release Tablets 500 mg
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2009-09-25
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 40
- Registration Number
- NCT00648076
- Locations
- 🇺🇸
Cedra Clinical Research, LLC., Austin, Texas, United States
Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Divalproex Sodium Extended-Release Tablets 500 mg
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2009-09-25
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 38
- Registration Number
- NCT00647712
- Locations
- 🇺🇸
Cedra Clinical Research, LLC., Austin, Texas, United States
Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 33
- Registration Number
- NCT00648882
- Locations
- 🇺🇸
PRACS Institute Ltd. - Cetero Research, Fargo, North Dakota, United States
Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 72
- Registration Number
- NCT00649194
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 22
- Registration Number
- NCT00648765
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Mylan Pharmaceuticals Inc
- Target Recruit Count
- 32
- Registration Number
- NCT00648557
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
© Copyright 2025. All Rights Reserved by MedPath